No Data
No Data
Is Chengdu Bright Eye Hospital Group (SZSE:301239) Using Too Much Debt?
Puri Ophthalmology: 2024 Semi-Annual Report Summary
Puri Ophthalmology: 2024 Semi-Annual Report
PRICONY (301239.SZ): The net income in the first half of the year was 43.2945 million yuan, a year-on-year decrease of 81.56%.
Prui Ophthalmology (301239.SZ) released its semi-annual report for 2024, with operating revenue of 1.42 billion yuan, a year-on-year increase of 3.08%; net profit attributable to shareholders of the listed company was 43.2945 million yuan, a year-on-year decrease of 81.56%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.31799 million yuan, a year-on-year decrease of 69.50%; basic earnings per share was 0.29 yuan.
Is It Too Late To Consider Buying Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)?
Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut
No Data
No Data